ACH
KDNY

ArrowMark Colorado Holdings’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

ArrowMark Colorado Holdings’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-4,190
Closed -$635K – 305
2015
Q2 		$635K Buy
+4,190
New +$692K 0.02% 259

Other funds holding KDNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
M&T Bank
M&T Bank Buffalo, New York $29.2B AUM 22.81% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

ArrowMark Colorado Holdings's KDNY Position: Q3 2015 in Review

ArrowMark Colorado Holdings sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2015, closing a stake of 4,190 shares — an estimated $635K sold.

ArrowMark Colorado Holdings first reported a position in KDNY in Q2 2015 and held it in 1 quarter. The position peaked at $635K in Q2 2015. 76 funds tracked by Wall St. Rank hold KDNY as of Q3 2015.

  • ArrowMark Colorado Holdings reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 4,190 Chinook Therapeutics, Inc. Common Stock shares in Q3 2015, an estimated $635K.
  • ArrowMark Colorado Holdings first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2015 and held it in 1 quarter.
  • ArrowMark Colorado Holdings's Chinook Therapeutics, Inc. Common Stock position peaked at $635K in Q2 2015.
  • 76 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2015.

Based on ArrowMark Colorado Holdings's 13F filing for Q3 2015, filed 16 Nov 2015.